Liquid Biopsy Applications in the Clinic.

Publication date: Jan 09, 2020

The global liquid biopsy industry is expected to exceed $US5 billion by 2023. One application of liquid biopsy technology is the diagnosis of disease using biomarkers found in blood, urine, stool, saliva, and other biological samples from patients. These biomarkers could be DNA, RNA, protein, or even a cell. More recently, the use of cell-free DNA from plasma is emerging as an important minimally invasive tool for clinical diagnosis. The development of technology has increased the diversity of its application. Here, we discuss how liquid biopsies have been used in the clinic, and how personalized medicine are likely to use liquid biopsies in the near future.

Chen, D., Xu, T., Wang, S., Chan, H., Yu, T., Zhu, Y., and Chen, J. Liquid Biopsy Applications in the Clinic. 06142. 2020 Mol Diagn Ther.

Concepts Keywords
Biomarkers Medicine
Biopsy Clinical medicine
Blood Branches of biology
DNA Biomarkers
Minimally Invasive Medical signs
Plasma Biotechnology
Protein Liquid biopsy
RNA
Saliva
Urine

Semantics

Type Source Name
disease MESH Biopsy
disease MESH diagnosis
disease MESH development

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *